MedPlus Health Services Limited has reported robust financial growth for the fiscal year ended March 31, 2026. The company achieved a consolidated annual revenue of ₹69,637.90 million, marking a significant increase over the previous year. Alongside strong financial performance, the company announced strategic leadership changes, including the appointment of new Non-Executive Independent Directors and the re-appointment of its Managing Director, reinforcing its commitment to long-term governance and operational excellence.
Financial Performance Highlights
For the fiscal year ending March 31, 2026, MedPlus delivered strong results. The consolidated total income rose to ₹69,637.90 million, compared to ₹61,846.69 million in the previous year. Net profit after tax for the year stood at ₹2,196.06 million, demonstrating clear year-on-year growth from ₹1,502.33 million reported in March 2025. These figures underscore the company’s sustained momentum in both its retail and diagnostic segments.
Segment Breakdown
The company’s retail segment remains the primary growth driver, contributing ₹67,601.06 million in revenue for the full year. The diagnostic services segment also showed improved performance, generating ₹1,309.87 million in revenue, reflecting the company’s successful expansion of its healthcare service offerings.
Strategic Leadership Updates
The Board of Directors has initiated several key leadership appointments to steer the company into its next phase of growth. Mr. Gangadi Madhukar Reddy has been re-appointed as Managing Director for a term of five years, starting August 3, 2026. Additionally, the company has appointed Mr. Ajit Pandurang Rangnekar and Mr. Mohankrishna Reddy Arvabumi as Non-Executive Independent Directors, effective May 20, 2026. These appointments bring decades of strategic and financial expertise to the leadership team.
Corporate Developments
During the meeting held on May 20, 2026, the Board approved the allotment of 82,419 equity shares under the Employees Stock Option Plan 2021. Furthermore, the company has finalized plans to conduct its 20th Annual General Meeting on Monday, August 17, 2026, via video conferencing.
Source: BSE
